DMAC EBITDA Margin
Diamedica Therapeutics Inc · EBITDA Margin
DMAC EBITDA Margin
Latest reported270494.94%period ending
DMAC TTM EBITDA Margin (-2420.16% → 270494.94%)
TTM ebitda margin
High-resolution chart · PNG
DMAC ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 270,494.9412% | |
| -1,796.4% | |
| -1,664% | |
| -1,131.4868% | |
| -951.6641% | |
| 2,537.5316% | |
| 3,640.576% | |
| 7,161.5412% | |
| -107,976.8847% | |
| -2,075.2056% | |
| -1,400.9065% | |
| -1,381.0653% | |
| -1,438.592% | |
| -1,348.4135% | |
| -1,944.851% | |
| -1,911.1661% | |
| -1,516.81% | |
| -2,735.6024% | |
| -1,701.8608% | |
| -5,333.0735% | |
| -2,420.163% |